MiReven Receives United States Patent

Perth, Western Australia (30 April, 2014)  MiReven Pty Ltd (mireven.com.au), an Australian microRNA company commercialising discoveries from the Harry Perkins Institute of Medical Research on the anti-cancer potential of miR-7, announces today the grant of its first patent by the United States Patent Office. The granted US patent, ‘Method Of Modulation of Expression of Epidermal […]